Novartis issued CHF 2.2 bn bonds

Advestra advised Novartis on the issuance of CHF 2.2 billion bonds, placed in five tranches as follows:

• the first tranche was issued in the prin­cip­al amount of CHF 650 million, with a coupon of 1.60% and a matur­ity date 2027.
• The second tranche in the prin­cip­al amount of CHF 435 million, with a coupon of 1.65% and a matur­ity date of 2031.
• The third tranche in the prin­cip­al amount of CHF 645 million, with a coupon of 1.75% and a matur­ity date of 2034.
• The fourth tranche in the prin­cip­al amount of CHF 280 million, with a coupon of 1.85% and a maturity date of 2040.
• The fifth tranche in the prin­cip­al amount of CHF 190 million, with a coupon of 1.85% and a matur­ity date of 2049.

UBS, BNP Pari­bas (Suisse) and Deutsche Bank Aktiengesell­schaft acted as joint lead man­agers and Zürch­er Kan­ton­al­bank acted as Co-Man­ager in this transaction.

Advestra’s team

Advestra acted as leg­al coun­sel to Novartis. The team included Annette Weber (pictured left) and Valérie Bayard (pictured center) (both cap­it­al mar­kets) as well as Céline Mar­tin (pictured right) (tax).